One of the goals of Dr. Carvalho's laboratory is to provide simple, cost-benefit, high-throughput technologies to distinguish various bacterial species from each other. These technologies are helpful in developing world hospitals, where the vast majority of the budget for health science is earmarked for HIV/AIDS, tuberculosis, and malaria. New technologies that are affordable for these developing world hospitals will improve their clinical microbiology work. This review gives an overview of one bacterial genus, Enterococcus, and discusses the issues facing clinical diagnostics for this genus in the developing world hospitals.
No comments:
Post a Comment